Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
monosaccharide/злокачественная опухоль
Ссылка сохраняется в буфер обмена
Страница 1 от 24 полученные результаты
Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The invention is directed to novel synthetic C-glycolipids, which are useful in treating cancer, infectious diseases and autoimmune diseases. Specifically, the invention is directed to novel synthetic analogs of .alpha.-C-galactosylceramides, which are potent mediators of
Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The invention is directed to novel synthetic C-glycolipids, which are useful in treating cancer, infectious diseases and autoimmune diseases. Specifically, the invention is directed to novel synthetic analogs of .alpha.-C-galactosylceramides, which are potent mediators of
Therapeutic method for selectively treating terminal deoxynucleotidyl transferase-positive neoplastic leukemias and lymphomas
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE lNVENTION
The present invention is concerned with anti-cancer therapies which utilize selective DNA polymerase substrate analogues as the basis for treatment and is directed to specific means for selectively employing the activity of terminal deoxynucleotidyl transferase, the unique DNA
Use of fructose-based compounds for the diagnosis of cancer
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF INVENTION
This invention relates to compositions, methods utilizing fructose and other monosaccharides for the diagnosis of cancer.
BACKGROUND
All publications herein are incorporated by reference to the same extent as if each individual publication or patent application was specifically
Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The present invention relates to pharmaceuticals that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis both in vitro and in vivo.
Background of the Invention
Cell adhesion is one important property that differentiates multi-cellular organisms from
Ameliorant for chemical treatment of cancer
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
This invention relates to a novel ameliorating agent for cancer chemotherapy. More particularly, this invention relates to an ameliorating agent for cancer chemotherapy containing as an active ingredient a water-soluble chromanol glycoside.
BACKGROUND ART
Cancers have been a disease
Monosaccharide derivatives
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to foreign patent application 1310/DEL/2006, filed May 30, 2006 in India.
FIELD OF THE INVENTION
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be
Glycopeptide for contrast agent targeting cancer cells and contrast agent kit containing the same
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims, under 35 U.S.C. .sctn. 119, the priority of Korean Patent Application No. 10-2015-0081418, filed on Jun. 9, 2015 in the Korean Intellectual Property Office, the disclosure of which is incorporated herein by reference in its
Method for treating tumors using cis-diammineplatinum (II) organophosphate complexes
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
This invention is concerned with cis-diammineplatinum(II) organophosphate complexes. More particularly, this invention is concerned with cis-diammineplatinum(II) organophosphate complexes, where the organophosphate moiety is either a glycerophosphate or a monosaccharide phosphate. These complexes
Levo-monosaccharide in a nucleoside analog for use as an anti-retroviral agent
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to compositions and methods for inhibiting reverse transcription, and, more particularly, to such compositions and methods for creating a nucleoside analog that disrupts the hybridization step during reverse
Acetates of 2-deoxy monosaccharides with anticancer activity
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Reliance on glycolysis has been correlated with disease progression in cancer, and as well as a consistent and significant increase in activity of hexokinase, phosphofructokinase and pyruvate kinase. Hypoxia is also a feature of many solid cancers and has been linked to
Methods and compositions for treatment of cell proliferative disorders
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
1. INTRODUCTION
The present invention relates to methods and compositions comprising at least one endothelin antagonist, preferably in combination with a poly-.beta.-1.fwdarw.4-N-acetylglucosamine (p-GlcNAc) polysaccharide matrix, for use in the treatment of cancer and other proliferative diseases.
Method of treating angiogenesis
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Growth factors comprise a family of polypeptides with a manyfold of properties regulating for example cell proliferation and cell metabolism. As being multi-functional molecules, they may stimulate or inhibit cell proliferation as well as affect cell function depending on the type of the target
Synthetic lipid-a-analogs and uses thereof
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The present invention relates to novel synthetic structural mimics of bacterial Lipid-A and methods of synthesis of such analogs. Bacterial Lipid-A compositions are being widely used as adjuvant to enhance the immune responses to various antigens used in vaccine formulations.
Tetraphenylbacteriochlorin derivatives and compositions containing the same
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
The present invention relates to tetraphenylbacteriochlorin derivatives, particularly, tetraphenylbacteriochlorin derivatives substituted by monosaccharide residues and their salts, a method of producing the same and compositions as photosensitizers containing the same, especially
Самая полная база данных о лекарственных травах, подтвержденная наукой
- Работает на 55 языках
- Травяные лекарства, подтвержденные наукой
- Распознавание трав по изображению
- Интерактивная карта GPS - отметьте травы на месте (скоро)
- Прочтите научные публикации, связанные с вашим поиском
- Ищите лекарственные травы по их действию
- Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов
Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.
